Dipyridamole - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dipyridamole and what is the scope of freedom to operate?
Dipyridamole
is the generic ingredient in three branded drugs marketed by Chartwell Injectable, Dr Reddys, Eugia Pharma Speclts, Fresenius Kabi Usa, Hikma, Hospira, Boehringer Ingelheim, Ani Pharms, Barr, Chartwell Rx, Glenmark Generics, Impax Labs, Oxford Pharms, Purepac Pharm, Rising, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.There are eighteen drug master file entries for dipyridamole. Nine suppliers are listed for this compound.
Summary for dipyridamole
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 17 |
NDAs: | 24 |
Drug Master File Entries: | 18 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 148 |
Clinical Trials: | 79 |
Patent Applications: | 6,750 |
Drug Prices: | Drug price trends for dipyridamole |
What excipients (inactive ingredients) are in dipyridamole? | dipyridamole excipients list |
DailyMed Link: | dipyridamole at DailyMed |
Recent Clinical Trials for dipyridamole
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Guo-Qing Jiang | N/A |
Clear Creek Bio, Inc. | Phase 2 |
Rutgers, The State University of New Jersey | Phase 3 |
Pharmacology for dipyridamole
Drug Class | Platelet Aggregation Inhibitor |
Physiological Effect | Decreased Platelet Aggregation |
Medical Subject Heading (MeSH) Categories for dipyridamole
Anatomical Therapeutic Chemical (ATC) Classes for dipyridamole
US Patents and Regulatory Information for dipyridamole
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms Usa Inc | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040874-001 | Jan 28, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Barr | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 087717-001 | Oct 3, 1990 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Oxford Pharms | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040542-001 | Apr 21, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Barr | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 087716-001 | Oct 3, 1990 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.